Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 3:53 pm Purchase | 13G | 180 Life Sciences Corp. ATNF | ARMISTICE CAPITAL LLC | 53,935 4.990% | 53,935 (New Position) | View |
2024-10-18 5:00 pm Purchase | 13G | 180 Life Sciences Corp. ATNF | Feldmann Marc | 90,532 8.600% | 90,532 (New Position) | View |
2024-02-14 3:27 pm Purchase | 13G | 180 Life Sciences Corp. ATNF | ARMISTICE CAPITAL LLC | 1,112,480 9.990% | 1,112,480 (New Position) | View |
2023-04-14 5:00 pm Sale | 13D | 180 Life Sciences Corp. ATNF | Feldmann Marc | 141,747 3.400% | -2,693,183 (-95.00%) | View |
2022-02-09 3:15 pm Sale | 13G | 180 Life Sciences Corp. ATNF | VANGUARD GROUP INC | 1,004,406 2.950% | -175,233 (-14.85%) | View |
2022-02-09 3:15 pm Sale | 13G | 180 Life Sciences Corp. ATNF | VANGUARD INDEX FUNDS | 1,004,406 2.950% | -64,994 (-6.08%) | View |
2022-02-07 4:30 pm Purchase | 13G | 180 Life Sciences Corp. ATNF | Nanchahal Jagdeep | 1,520,564 4.500% | 199,949 (+15.14%) | View |
2021-12-13 4:21 pm Purchase | 13D | 180 Life Sciences Corp. ATNF | Feldmann Marc | 2,834,930 8.200% | 238,082 (+9.17%) | View |
2021-02-10 10:30 am Purchase | 13G | 180 Life Sciences Corp. ATNF | VANGUARD GROUP INC | 1,179,639 6.540% | 1,179,639 (New Position) | View |
2021-02-08 10:37 am Purchase | 13G | 180 Life Sciences Corp. ATNF | VANGUARD INDEX FUNDS | 1,069,400 5.930% | 1,069,400 (New Position) | View |
2020-12-31 2:32 pm Purchase | 13G | 180 Life Sciences Corp. ATNF | BAUER RONALD | 2,280,171 9.200% | 2,280,171 (New Position) | View |
2020-12-30 5:00 pm Sale | 13D | 180 Life Sciences Corp. ATNF | KBL IV SPONSOR LLC | 2,522,199 10.250% | -402,124 (-13.75%) | View |
2020-12-29 1:22 pm Purchase | 13G | 180 Life Sciences Corp. ATNF | BRIDGMAN CRAIG | 1,753,543 11.000% | 1,753,543 (New Position) | View |
2020-12-11 3:09 pm Purchase | 13G | 180 Life Sciences Corp. ATNF | Nanchahal Jagdeep | 1,320,615 5.300% | 1,320,615 (New Position) | View |
2020-11-18 4:28 pm Purchase | 13D | 180 Life Sciences Corp. ATNF | Feldmann Marc | 2,596,848 10.500% | 2,596,848 (New Position) | View |
2020-11-16 5:00 pm Purchase | 13D | 180 Life Sciences Corp. ATNF | KBL IV SPONSOR LLC | 2,924,323 11.900% | 2,924,323 (New Position) | View |
2020-02-14 07:31 am Purchase | 13G | 180 Life Sciences Corp. ATNF | MIZUHO FINANCIAL GROUP INC MFG | 421,943 5.200% | 421,943 (New Position) | View |
2020-02-13 11:17 am Sale | 13G | 180 Life Sciences Corp. ATNF | Weiss Asset Management LP | 0 0.000% | -1,162,038 (Position Closed) | View |
2020-02-12 5:02 pm Sale | 13G | 180 Life Sciences Corp. ATNF | BOOTHBAY FUND MANAGEMENT LLC | 0 0.000% | -865,963 (Position Closed) | View |
2020-02-07 12:27 pm Sale | 13G | 180 Life Sciences Corp. ATNF | BASSO CAPITAL MANAGEMENT L.P. | 24,800 0.300% | -505,974 (-95.33%) | View |